| Drug Name |
Nevirapine |
| Drug ID |
BADD_D01557 |
| Description |
A potent, non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination with nucleoside analogues for treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infection and AIDS. Structurally, nevirapine belongs to the dipyridodiazepinone chemical class. |
| Indications and Usage |
For use in combination with other antiretroviral drugs in the ongoing treatment of HIV-1 infection. |
| Marketing Status |
approved |
| ATC Code |
J05AG01 |
| DrugBank ID |
DB00238
|
| KEGG ID |
D00435
|
| MeSH ID |
D019829
|
| PubChem ID |
4463
|
| TTD Drug ID |
D0O2EM
|
| NDC Product Code |
53104-7546; 70159-002; 65862-027; 0378-4050; 64380-709; 65862-932; 65862-933; 31722-505; 65862-057; 68554-0044; 33342-004; 0597-0047; 64220-102; 0378-4890; 65162-209; 33342-238; 42571-131 |
| UNII |
99DK7FVK1H
|
| Synonyms |
Nevirapine | Nevirapine Hemihydrate | Hemihydrate, Nevirapine | Viramune | BI-RG-587 | BI RG 587 | BIRG587 |
